Contactless technique developed to detect viruses on surfaces
A prototype technique to remotely detect viruses deposited on a surface has been developed by researchers in Spain.
The ongoing project, carried out by the...
Malaria transmission potentially eradicated with discovery of new microbe
A team of scientists in Kenya has uncovered a new microbe that may effectively mitigate malaria transmission, creating new methods to combat the deadly...
Common tapeworm drugs may provide new COVID-19 treatment
A novel investigation has indicated that a range of widely utilised tapeworm drugs may also work as an effective COVID-19 treatment.
The research, conducted by...
Cholesterol drug could reduce SARS-CoV-2 infection by up to 70%
Scientists have identified a licensed drug that they say could significantly reduce the risk of COVID-19 infection.
An international study, led by the University of...
Double vaccine dose halves COVID-19 infection risk, study estimates
COVID-19 infection rates in England are three times lower in double vaccinated people, the findings from the recent REACT-1 report have revealed.
The latest findings...
Researchers issue warning on relaxing COVID-19 restrictions
Prematurely relaxing COVID-19 restrictions could lead to vaccine resistance, researchers warn.
Scientists from the University of East Anglia and the Earlham Institute have said that...
Behind the mask: examining the evolution and rise of PPE
Alison Margary, British Occupational Hygiene Society, explains why the pandemic's use of PPE should make us re-evaluate disease prevention.
COVID-19 has introduced the acronym PPE...
Innovations in hydrogel technology are transforming wound care
Using revolutionary technology, hydrogel wound care can help prevent unnecessary infection and heal wounds before they become chronic.
The benefits of employing antimicrobial peptides in...
Close contact testing effectively controls COVID-19 spread in schools
Daily close contact testing in secondary schools was as successful at preventing COVID-19 transmission as the current ten-day isolation policy, new research has found.
In...
XPhyto expands infection prevention offering with new acquisition
Lifesciences specialist XPhyto Therapeutics has recently acquired 3a Diagnostics in a bid to advance its infection-prevention solutions.
The move is the latest development in XPhyto’s...
How to support a return to ‘normal’ life after COVID-19
Belgian company miDiagnostics is developing an ultrafast RT-qPCR COVID-19 test which could accelerate a return to international travel.
The COVID-19 pandemic has highlighted the challenges...
Sanitisation stands: a weapon against germs and infectious bacteria
The need for hand sanitisers is everywhere. They have become a crucial public health aid.
Sanitisation stands help the fight against the spread of pathogens...
The wearable device making hand hygiene easy and effective
Adam Sutcliffe, Founder and CEO of Orbel, explains how the company's wearable hand sanitisation device is encouraging good hygiene practices.
Practising good hand hygiene is...
Killing viruses with Wela Group’s new AVAST™ system
The AVAST™ unit has been specifically developed to aid in killing viruses and infection outbreaks across multiple industries.
In response to the ever-increasing demand for...
UVC-BAK dual disinfection heralds a new age of infection control
Dr David McCanna and Jacob Sivak talk to HEQ about how UVC can change the face of disinfection and its environmental impact.
Following the outbreak...
Vaccine cold chain specialists B Medical Systems announce new partnership
Global leaders of vaccine cold chain technology, B Medical Systems, have revealed that they will be collaborating with India’s 1mg, a leading digital consumer...
Diversey’s Degragerm 24 Shield: Ensuring residual surface disinfection
Diversey’s Degragerm 24 Shield offers 24-hour disinfection protection from microbial contamination of surfaces.
To achieve optimal levels of hygiene, environmental surfaces and equipment in public...
Research shows CoronaVac COVID-19 vaccine is safe and effective
An interim analysis of the phase 3 control trial has proven the CoronaVac COVID-19 vaccine to be safe and effective at preventing infection.
The findings,...
Working towards a solution for frequent global mass COVID-19 testing
Achiko’s President, Dr Morris S. Berrie, explains how the company’s innovative AptameX™ technology could offer a sustainable solution to mass COVID-19 testing.
Since the outbreak...
New COVID-19 insights could improve outcomes for transplant patients
People who have received a solid organ transplant are more likely to suffer from severe COVID-19 infection, new research has found.
A team of researchers...
